Mutagenicity and metabolism of vinyl chloride and related compounds. by Bartsch, H et al.
Environmental Health Perspectives
Vol. 17, pp. 193-198, 1976
Mutagenicityand Metabolism of Vinyl Chloride and
Related Compounds
by H. Bartsch,*t C. Malaveille,* A. Barbin,* H. BresiI,* L Tomatis,* and R.
Montesano*
The various adverse biological effects of vinyl chloride appear to be dependent upon
the metabolic conversion of this compound into chemically reactive metabolites. The
metabolism of vinyl chloride in mammals and in man, including the formation of
monochloroacetic acid and some identified sulfur conjugates is reviewed. Hepatic micro-
somal mixed function oxidases from rats, mice, and humans were equally effective in
transforming vinyl chloride into alkylating agents in vitro. Two of the enzyme reaction
products, i.e., chloroethylene oxide and 2-chloroacetaldehyde, showed potent genetic
activity in microorganisms and Chinese hamster V79 cells. The role of liver microsomal
enzymes in the generation of electrophilic mutagenic vinyl chloride metabolites is
discussed.
Chlorinated hydrocarbons, such as vinyl
chloride (VCM) or vinylidene chloride, are
widely used in the production of plastic resins
and are present in the environment (1, 2). It
is now recognized that VCM is responsible for
various adverse biological effects which induce
neoplastic and nonneoplastic diseases in man
as well as in animals (2) and that these effects
seem to be attributable not to VCM itself but
to reactive metabolites formed by microsomal
mixed-function oxidases. Many chemical car-
cinogens have been shown to exert a carcino-
genic effect following their metabolic activa-
tion into elctrophilic metabolites which react
readily with cellular macromolecules (3).
This paper is a review of results obtained in
our laboratory and by others concerning the
mutagenicity of VCM and related compounds
and the metabolism of some of these com-
pounds.
Mutagenicity
The mutagenicity of VCM has been examined
in various strains of S. typhimurium in which
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the genetic indicator reverts to histidine pro-
totrophy by single-base pair substitutions (G-
46, TA1530 and TA1535) and in strains
TA1536, TA1537 and TA1538 which revert by
base-pair insertions and deletions, or "frame-
shifts" (8).
Mutagenic responses were observed only in
S. typhimurium strains which revert by single
base-pair substitutions and not in strains
TA 1536, TA1537 and TA1538 which are spe-
cifically reverted by frameshift mutagens (4,
5). Exposure of S. typhimurium strain TA1530
in a soft layer to 20% VCM (v/v) in air in the
absence of a mammalian metabolic activation
system caused a linear increase in the muta-
genic response as a function of incubation
time (Fig. 1). This mutagenic effect could be
attributed to nonenzymic breakdown products
of VCM or to a compound(s) formed by bac-
terial enzyme systems. However, a much higher
mutagenic response was observed in the pres-
ence of a fortified liver postmitochondrial su-
pernatant from phenobarbitone-pretreated mice
added to the assay systems (Fig. 1). A similar
increase in the mutagenic response was noted
with 9000 g liver supernants from phenobarbi-
tone-pretreated or untreated rats (4, 5). In the
TA1530 strain, which showed the highest mu-
tagenic response, the number of his+ revertant
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and pooled liver fractions from five phenobarbitone-
pretreated mice, following exposure of the bacteria
to 20% VCM in air at 37°C in the presence of: (o)
a 9000g supernatant and a NADPH-generating sys-
tem; (A*) a 90009 supernatant, a NADPH-generat-
ing system, NAD+ (4,umole/plate) and alcohol de- hyur1ogease (5.9 Units/plate); (x) a 100,O09 super-
natant, a NADPH-generating system, NAD+, and
alcohol dehydrogenase; (e*) KOl and NADP+ only.
colonies increased approximately 6, 12 and 28
times over the number of spontaneous muta-
tions after exposure to 0.2, 2.0, and 20% VCM
(v/v), respectively, in air for 48 hr (4). Simi-
lar results were obtained by Rannug et al. (9)
and by McCann et al. (10) using S. typhtmu-
rium strains TA1535 and TA100.
Loprieno et al. (411l) reported a dose-related
mutagenic response in the yeast Saceharomyces
pornibe when it was incubated with fortified
mouse-liver microsomes and flushed with 50%
VCM in air; no mutagenic response was ob-
served when liver microsomes were omitted
from the incubation mixture. In the same in-
cubation system, VCM induced a significant
increase in gene conversion frequency in S.
cerevisiae D4 strain_ at the adeni-ne-2 and
tryptophan-5 loci (11).
These data strongly support the hypothesis
that VCM requires biotransformation by mam-
malian liver enzymes in order to manifest its
genetic effects.
Table 1. Effects of various subcellular tissue fractions
on the mutagenic response to VCM.a
Mouse liver fraction b No. of his + rev./plate
None (KCl) 96 ± 38
9000 g supernatant (S-9) 310 ± 18
Microsomal fraction 175 ± 20
Cytosol 138 ± 12
Microsonal fraction + cytosol 501 ± 25
a Data of Malaveille et al. (5).
b Equivalent to 38 mg of wet tissue/plate; NADPH
generating system present.
cMutagenicity assays with strain TA1530; 6 hr ex-
posure to 20% VCM in air at 370C. No. of spontaneous
mutations/plate (10 + 3) subtracted from each value.
Mean values + S.D. from three mutagenicity assays,
each utilizing pooled liver tissue from five PB-pre-
treated mice.
Malaveille et al. (5) investigated the sub-
cellular localization of the VCM activating en-
zyme(s) by assaying various liver fractions
from phenobarbitone-pretreated mice (Table
1) for their capacity to form a VCM meta-
bolite (s) mutagenic for Salmonella typhimu-
rium TA1530 strain. In the presence of a
NADPH-generating system (NADP+ and glu-
cose-6-phosphate), the highest enzyme activity
was found to be localized in either the 9000
g supernatant or in the recombined microsomal
and soluble protein fraction. Purified liver
microsomal fractions plus VCM induced a
lower mutagenic response, and the omission of
the NADPH-generating system from the as-
says resulted in a number of his+ revertants
similar to that in control assays containing
KCI only. Soluble liver proteins (100,000 g
supernatant) did not increase the mutagenic
response to UCM. The addition of alcohol de-
hydrogenase and NADP+ to either the fortified
postmitochondrial fraction or to the lOO,OOOg
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genic response to VCM (Fig. 1).
The involvement of microsomal enzymes in
VCM metabolism was further demonstrated by
the changes in the tissue-mediated mutageni-
city of VCM resulting from administration of
modulators of microsomal mixed-function oxi-
dases to animals. The addition of postmito-
chondrial liver fractions from phenobarbitone-
pretreated rats or mice resulted in an increased
mutagenic response in vitro when compared
with that in the presence of fractions from
untreated animals (4, 5). Incubation media
containing 9000 g liver fractions from rats
pretreated with aminoacetonitrile, pregneno-
lone-16a-carbonitrile or bis(diethylthiocarba-
moyl) disulfide (disulfiram) reduced the liver
enzyme-mediated mutagenic effect of VCM in
S. typhimurium TA1530 (2). The reduction in
the mutagenic effect of VCM observed when
disulfiram was added directly to assay systems
containing 9000 g liver fractions from mice can
be explained either as a direct effect on micro-
somal enzyme activity or by the presence of
nucleophilic SH-groups formed from cleavage
of disulfiram, which could compete for the
binding of the mutagenic metabolites to bac-
terial DNA.
Bartsch et al. (4) and Malaveille et al. (5)
compared the mutagenic effects in S. typhi-
muriunt TA1530 strain of various putative or
identified vinyl chloride metabolites. VCM
(monochloroethylene) is oxidized in vitro by
microsomal mixed-function oxidases to chloro-
ethylene oxide, which rearranges spontaneously
to chlororoacetaldehyde (12) Hefner et al. (13)
have proposed that 2-chloroethanol is an in-
termediate in the metabolism of vinyl chloride
or VCM, and monochloroacetic acid is a VCM
metabolite which has been identified in the
urine of rats and humans (14, and see next
section). Three of the four VCM derivatives
tested in S. typhimurium TA1530 strain ex-
erted a mutagenic effect; monochloroacetic
acid had only a toxic effect. Chloroethylene
oxide elicited the strongest mutagenic response
but had a relatively low toxicity when com-
pared to that of 2-chloroacetaldehyde, which
was also found to be mutagenic. 2-Chloro-
ethanol increased the number of his+ revert-
ants to 10 times the spontaneous mutation
rate, only in the presence of a post-mitochon-
drial mouse liver fraction. The postmitochon-
drial mouse liver fraction decreased the muta-
genic effect of 2-chloroacetaldehyde.
Similarly, in S. typhimurium TA100 strain,
only 2-chloroacetaldehyde and 2-chloroethanol,
and not monochloroacetic acid, were found to
be mutagenic (10). In a more detailed study,
Rannug et al. (15) also examined the muta-
genicity of these four VCM metabolites in S.
typhimurium TA1535; he reached the conclu-
sions that chloroacetaldehyde was less effective
by a factor of 1000, than chloroethylene oxide
in inducing point mutation in this strain and
that 2-chloroethanol is unlikely to be respon-
sible for the mutagenicity of VCM in this test
system. Monochloroacetic acid was not muta-
genic at any concentration tested.
Similar results were obtained by Huberman
et al. (6) in Chinese hamster V-79-4 cells: a
dose-dependent induction of 8-azaguanine- or
oubain-resistant mutants was observed with
chloroethylene oxide, where as 2-chloroacetal-
dehyde induced only 8-azaguanine-resistant mu-
tants and resulted in a high cytoxicity. 2-Chlo-
roethanol and monochloroacetic acid were in-
active even at concentrations up to 100 times
as high.
Metabolism
The pharmacokinetics and tissue distribution
of 14C-labeled VCM in rats exposed by various
routes to different concentrations was reported
by Watanabe et al. (16, 17). For animals ex-
posed to 1000 ppm 14C-VCM for 6 hr, 56% of
the radioactivity was excreted in urine, 12%
was expired as VCM, 12% was expired as
14CO., and 4% was found in the feces within
72 hr. For animals administered 10 ppm within
6 hr, 68% of the 14C radioactivity was recov-
ered from the urine and 2% in expired 14C-
VCM. With single oral or intraperitoneal ad-
ministration, low doses of VCM resulted in
higher excretion of radioactivity in the urine
and lower exhalation as 14C-VCM, while high
dose levels resulted in the opposite pattern of
elimination (17, 18). Following a single intra-
venous injection of 250 uag/kg 14C-VCM, 80%
of the radioactivity was detected within a few
minutes in the exhaled air as unchanged VCM
(18). Of the various tissues examined, the liver
and skin retained the highest levels of radio-
activity (16, 17).
These data indicate that at low doses VCM
is metabolized to polar metabolites which are
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urinary metabolites detected have been iden-
tified as N-acetyl-S- (2-hydroxyethyl)-cys-
teine and thiodiglycolic acid, suggesting that
the primary VCM metabolites are excreted in
the urine as gluthathione or cysteine conju-
gates. No qualitative or quantitative differ-
ences among these metabolites were observed in
rats with the various doses and exposures ex-
amined (19).
The occurrence of these urinary metabolites
substantiates the evidence provided previously
(2) that VCM (I) is metabolized by micro-
somal mixed-function oxidases to a primary re-
active metabolite, chloroethylene oxide (II),
which rearranges to chloracetaldehyde (III);
a further oxidation leads to monochloroacetic
acid (IV).
mental conditions, 2-chloroacetaldehyde showed
no reactivity (7).
As chloroethylene oxide readily rearranges
to 2-chloroacetaldehyde (23), this latter, vola-
tile compound has been detected after the me-
tabolic conversion of VCM by liver microsomal
mixed-function oxidases and oxygen (24). The
primary reactive metabolite, chloroethylene
oxide, could be detected in vitro when a mix-
ture of VCM and oxygen (1:1, v/v) was passed
through a medium containing liver microsomes
from phenobarbitone-pretreated mice and a
NADPH generating system. A volatile meta-
bolite was trapped with 4-(p-nitrobenzyl)py-
ridine in ethylene glycol, and its absorption
spectrum was shown to be identical with that
obtained from chloroethylene oxide (Fig. 2),
NADPH, 02{ H / 1
II
- Cl CH,CHO C1 CH2-COOH
III IV
The metabolic activation of VCM to a mu-
tagenic metabolite(s) by liver microsomal sys-
tems from various animal species as well as
from humans has been shown to be dependent
on the presence of the cofactors necessary for
mixed-function oxidase reactions (NADPH-
generating system and oxygen) (4, 9, 11).
With 14C-VCM, it has been demonstrated that
liver microsomes in the presence of the neces-
sary cofactors are essential for the binding of
a VCM metabolite(s) to cellular macromole-
cules (20, 21).
Administration of inducers and inhibitors of
drug metabolizing enzymes to animals has been
shown to modify microsome-mediated binding
to nucleic acids and the mutagenicity of VCM
in vitro (2, 22). The potent mutagenic activity
of chloroethylene oxide, when compared to that
of the other VCM metabolites examined (5,
15), strongly suggests that this alkylating me-
tabolite is responsible for the adverse biological
effects of VCM. In an aqueous solution at pH
7.4 and 37°C, chloroethylene oxide has a half-
life of 1.6 min, and its strong alkylating activ-
ity was demonstrated by its reaction with 4-(p-
nitrobenzyl)pyridine. Under the same experi-
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FIGURE 2. Absorption spectra of VCM, metabolites with
4-(p-nitrobenzyl) pyridine: absorption spectra re-
corded after reaction of 4-(p-nitrobenzyl)pyridine
with (0) chloroethylene oxide or (A) with 2-chloro-
acetaldehyde; spectrum of VCM recorded by passing
a mixture of VCM/oxygen through a medium con-
sisting of liver microsomes from phenobarbitone-pre-
treated mice and a NADPH-generating system and
reacting the volatile metabolite with 4-(p-nitro-
benzyl)pyridine in ethylene glycol; (C) control in
which NADP+ and glucose-6-phosphate were omitted
(7).
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196Table 2. Comparative mutagenicities of olefinic compounds.,
his+ revertant colonies/ymole/hr/plate b
TA1530 TA100
Compound + cofactorsC - cofactors + cofactorsc - cofactors Carcinogenicity
Vinyl acetate 0 0 0 0
Vinyl chloride 3.7 1.2 5.6 1.5 +
Vinylidene chloride 9.5 0.2 14.6 0.7 ?
2-Chlorobutadiene 34.5 12.5 51.2 9 ?
a Data of Bartsch et al. (30,31).
b From linear dose- and time-dependent response curves in the presence of mouse liver 9000g supernatant; spon-
taneous mutations subtracted.
c NADP+, glucose-6-phosphate.
whereas a different spectrum was observed for
2-chloroacetaldehyde. In the absence of a
NADPH generating system, no such product
was formed from VCM.
In another series of experiments, Barbin et
al. (7) showed that chloroethylene oxide or 2-
chloroacetaldehyde react covalently with ade-
nosine in vitro. After chromatography on Se-
phadex G-10, some of the reaction products
obtained from VCM and adenosine in the pres-
ence of a microsomal system were eluted at
positions similar to those found with chloro-
ethylene oxide or 2-chloroacetaldehyde. 2-Chlo-
roacetaldehyde reacts in vitro with adenosine
and cytidine to give fluorescent products (25).
Mutagenicity tests similar to those used in
the studies on VCM were used to investigate
some related olefinic compounds which are also
used in the plastic and rubber industries (2,
27). Table 2 lists the relative mutagenic
strengths (number of his+ revertant colonies/
Amole of substrate/hr of exposure/plate) in-
duced both directly and when mediated bymouse
liver enzyme of VCM, vinylidene chloride (1,1-
dichloroethylene) and 2-chloro-1,3-butadiene
(chloroprene) in S. typhimurium strains TA-
1530 and TA100. 2-Chlorobutadiene exhibited
the highest microsome-mediated mutagenic ef-
fect and was also mutagenic in the absence
of the mouse liver microsomal fraction. With
vinylidene chloride, no mutagenic effect was
observed when the microsomal activation sys-
tem was omitted from the incubation mixture.
Vinyl acetate, a noncarcinogenic compound
(28), was not mutagenic in this experimental
system. Data on the carcinogenicity of vinyli-
dene chloride and 2-chlorobutadiene in animals
are not yet available, but long-term carcino-
genicity tests are under way in the IARC
laboratory and at other institutes.
Since epoxides are now recognized to be obli-
gatory intermediates in the metabolism of
many olefinic compounds by hepatic microsomal
mixed-function oxidases (29), it can be postu-
lated that they may be the primary reactive
metabolites of these compounds. This is
strongly suggested to be true for VCM. Micro-
somal fractions of human liver biopsy speci-
mens have also been shown to metabolize these
halogenated olefins into mutagenic and electro-
philic metabolites (30).
Conclusions
The experimental data available at present
strongly support the concept that the biological
effects of VCM are related to its conversion by
microsomal enzymes into chemically reactive
alkylating agents which can bind covalently
to various cellular macromolecules. A similar
mechanism of action has been implicated for
other classes of carcinogens.
Based on mutagenicity studies with various
genetic indicators, the data strongly suggest
that chloroethylene oxide is the VCM metabo-
lite principally responsible for the various ad-
verse biological effects of the parent compound.
The role of chloroacetaldehyde in VCM carcino-
genesis needs to be studied in long-term carcin-
ogenicity tests, but its diacetal derivative has
been reported to be noncarcinogenic (26).
October 1976The increasing evidence of an empirical cor-
relation between the carcinogenic and muta-
genic effects of chemicals, together with the
present findings, emphasize the need for a care-
ful evaluation of the carcinogenic potential of
those chemicals structurally related to VCM.
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